Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000904454-20-000173
Filing Date
2020-02-13
Accepted
2020-02-13 17:07:22
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCH 13G/A FILING BY MFN PARTNERS FOR ISSUER CYCLERION THERAPEUTICS, TO BE FILED s13ga_021020-cyclerion.htm SC 13G/A 113309
  Complete submission text file 0000904454-20-000173.txt   114736
Mailing Address 222 BERKELEY STREET, 13TH FLOOR BOSTON MA 02116
Business Address 222 BERKELEY STREET, 13TH FLOOR BOSTON MA 02116 617-443-2040
MFN Partners Management, LP (Filed by) CIK: 0001732811 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
Type: SC 13G/A

Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617-621-7722
Cyclerion Therapeutics, Inc. (Subject) CIK: 0001755237 (see all company filings)

EIN.: 831895370 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90979 | Film No.: 20611881
SIC: 2834 Pharmaceutical Preparations